Biotech · Private company
PolarityTE
Track this companyFree. Adds PolarityTE to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- ControlPhase 3 · Diabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- SkinTEPhase 3 · Diabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- Additional Outer Dressing ApplicaitonDiabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- Additional Outer Dressing ApplicationVenous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Fibracol Wound DressingDiabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- Fibracol Wound DressingVenous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Human Autologous Homologous Skin ConstructDiabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- Human Autologous Homologous Skin ConstructVenous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- OffloadingDiabetic FootClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)PHASE3 · COMPLETED · started Feb 22, 2024ClinicalTrials.gov NCT06140303 · fetched Nov 12, 2026
- Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUsPHASE3 · TERMINATED · started Apr 28, 2022ClinicalTrials.gov NCT05372809 · fetched Nov 12, 2026
- SkinTE™ in the Treatment of Diabetic Foot WoundsNA · COMPLETED · started Apr 2, 2019ClinicalTrials.gov NCT03881254 · fetched Nov 12, 2026
- SkinTE® in the Treatment of Venous Leg WoundsNA · COMPLETED · started Mar 29, 2019ClinicalTrials.gov NCT03881267 · fetched Nov 12, 2026